Cyclic Voltammetric Studies of Nitroimidazoles in DMSO in the Presence of Cysteine and Other Weak Acids. Implications for the Biological Reactivity of Nitroimidazoles
Author(s) -
Diane K. Smith,
Theresa Andres,
Maurice Horton,
Samvel Avagyen,
Kerry Javery,
Karen An Callera Ronquillo,
Eqlema Roshnaye,
Hayem Said
Publication year - 2013
Publication title -
meeting abstracts/meeting abstracts (electrochemical society. cd-rom)
Language(s) - English
Resource type - Journals
eISSN - 2151-2035
pISSN - 1091-8213
DOI - 10.1149/ma2013-01/13/624
Subject(s) - reactivity (psychology) , chemistry , cysteine , organic chemistry , combinatorial chemistry , medicine , alternative medicine , pathology , enzyme
A number of nitroimidazoles (NI’s) are used as drugs to treat a variety of infections by anaerobic microorganisms. In all cases the NI’s are believed to require in vivo reduction in order to be activated. However, the actual active forms of the drugs as well as the mechanisms of action are not known for certain. One widely accepted theory is that the active form is a 1 e reduction product, either the radical anion or the protonated radical, which causes cell death by inflicting extensive damage to the organism’s DNA. Other research suggests that it may be the 2 e product, the nitroso, that is the active species. Nitrosobenzenes are known to react with thiols like glutathione and cysteine in vitro and in vivo. Thus an alternative hypothesis is that cell death is caused by deactivation of key proteins and/or the disturbance of cellular redox balance due to adduct formation between the NI and cysteine residues.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom